Wlanholding
Family officeVienna · Seed–Growth · 1 people tracked
Investment thesis
Wlanholding invests in transformative technologies across two megatrends: high-tech life science and high-tech-driven sustainability. Acting as an entrepreneurial, hands-on partner, the firm backs passionate founders and management teams to scale innovative businesses. It offers angel/seed capital as well as growth capital, typically following its initial investments up to at least Series B. The firm emphasizes long-term impact over quick exits, contributing expertise in governance, branding, business building, growth financing, IPOs, and M&A. Its investment activities are supported by Dr. Lanthaler's track record of four completed IPOs and more than 15 M&A transactions.
Source: firm website, verified Aug 7, 2026.
Team · 1 people
from the firm's website
What they invest in
from 8 of 9 portfolio companiesBiotech ×4AI & Machine Learning ×2Construction Tech ×2Deep Tech ×2Healthtech ×2New Materials ×2AdTech ×1Circular Economy ×1
HQs:Austria×2Germany×1
Investments · 9 tracked
founders shown can be your intro pathALAS Baustoff-Holding is an owner-managed producer and supplier of gravel, stone, aggregates, and ready-mix concrete, and also handles recycling and disposal of excavation and mineral construction debris.
Circular EconomyConstruction TechNew Materials
Cerabyte develops long-term, sustainable data storage technology aimed at preserving digital records permanently.
Data & InfrastructureDeep TechHardware
PartnerWerner Lanthaler· solo GP
Co-investorsArmada Investment AGNovaCapital
CookieYes is a cookie consent management platform that helps businesses comply with global data privacy regulations including GDPR, CPRA, and LGPD.
AdTechEnterprise SoftwareSaaSUnited Kingdom, India
Anvar T K(Founder)in
Co-investorsAdvantage Capital PartnersBrighteye VenturesCapitânia InvestimentosChemistryE4E AfricaEight Roads Ventures+16 more
cyment produces innovative raw material mixtures for ecological cement and concrete production, reducing CO₂ emissions in construction.
CleantechConstruction TechNew MaterialsBorder region of Austria, Slovakia, and Hungary, AT
PartnerWerner Lanthaler· solo GP
AI & Machine LearningBiotechDigital Health
Co-investors42CAPAir Street CapitalPUSH Ventures
Pexxes develops affordable biologic therapeutics for treating chronic diseases in dogs, cats, and horses.
BiotechHealthtechHannover, DE
Dr. Katharina Böhme(CEO and Co-founder)Dr. Cornelia Schwennen(COO and Co-founder)
PartnerWerner Lanthaler· solo GP
PartnerWerner Lanthaler· solo GP
Proxygen discovers glue degraders, a novel drug modality that targets protein interactions for therapeutic treatments.
Biotech
PartnerWerner Lanthaler· solo GP
Solgate is a drug discovery company developing small-molecule drugs that target solute carrier (SLC) membrane transporter proteins, using a platform combining chemical, biological, and computational technologies.
AI & Machine LearningBiotechDeep TechHealthtechKlosterneuburg, AT
PartnerWerner Lanthaler· solo GP
Exits · 1
IPOs and acquisitions across the tracked portfolioExscientia (NASDAQ: EXAI)acq. by Recursion
Frequently asked questions
- How many investments has Wlanholding made?
- Wlanholding has 9 tracked investments.
- What stage does Wlanholding invest at?
- Wlanholding invests at the Seed, Series A, Series B, Growth stages.
- What sectors does Wlanholding focus on?
- Wlanholding focuses on Biotech, Cleantech, Climate Tech, Deep Tech, Healthtech, Impact & Social Good, Longevity, New Materials, Sector Agnostic.
- Where is Wlanholding located?
- Wlanholding is headquartered in Vienna, AT.
- Who does Wlanholding co-invest with?
- Wlanholding most often shares deals with Brighteye Ventures, Eight Roads Ventures, Entrepreneur First, among 27 tracked co-investors.
Similar investors
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Northstar Ventures is a UK venture capital firm based in the north of England that invests in early and later stage high-growth companies tackling global challenges, with a focus on climate tech and healthy ageing.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
.png)
Better Ventures is an early-stage venture capital firm backing mission-driven technology companies working to build a better world across climate, health, and workforce sectors.